The Patent Finder

Nuclea Biotechnologies, Inc.

Also on record
Records under this name other than the patents Nuclea Biotechnologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Nuclea Biotechnologies, Inc.

PatentTitleStatus Expires Confidence
US 7,897,354Kinase peptides and antibodies
Lapsed on the fee record
Ended Mar 1, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 1, 2023From the USPTO record
US 8,900,820Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
Lapsed on the fee record
Ended Dec 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 2, 2022From the USPTO record
US 9,739,781Anti-phospho-Akt antibodies
Lapsed on the fee record
Ended Aug 22, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2021From the USPTO record
US 9,732,158Antibodies against fatty acid synthase
Lapsed on the fee record
Ended Aug 15, 2021 · From the USPTO record
Lapsed on the fee recordEnded Aug 15, 2021From the USPTO record
US 6,534,307Frozen tissue microarrayer
Term ended
Term ended Jun 28, 2021 · From the USPTO record
Term endedTerm ended Jun 28, 2021From the USPTO record
US 8,129,125Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
Lapsed on the fee record
Ended Mar 6, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2020From the USPTO record
US 9,056,919USP2A Peptides and Antibodies
Lapsed on the fee record
Ended Jun 16, 2019 · High confidence
Lapsed on the fee recordEnded Jun 16, 2019High confidence
US 9,029,512Anti-phospho-Akt antibodies
Lapsed on the fee record
Ended May 12, 2019 · From the USPTO record
Lapsed on the fee recordEnded May 12, 2019From the USPTO record
US 8,729,239Antibodies against fatty acid synthase
Lapsed on the fee record
Ended May 20, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 20, 2018From the USPTO record
US 8,685,891Method and assay for determining FAS expression
Lapsed on the fee record
Ended Apr 1, 2018 · From the USPTO record
Lapsed on the fee recordEnded Apr 1, 2018From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited